LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel
non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1
nM) and selectivity. It's in a class of androgen receptor (AR) ligands
that is tissue selective, developed to treat muscle wasting associated
with cancer, acute and chronic illness and age-related muscle loss.
LGD-4033 is expected to produce the therapeutic benefits of test-oste-
oral route of administration.Best Sarms Powder
How LGD-4033 Works?
LGD-4033 works by tying androgen receptors selectively. It shows
anabolic activity in the bones and muscles instead of harmfully
affecting the prostate and sebaceous glands which usually happens when
using st-er LGD-4033 just concluded a study called Phase I Multiple
Ascending Dose which included fit volunteers. This was an unplanned,
double bind analysis stage that included a placebo. The objective was to
form that using LGD-4033 was harmless and easy to stomach with a dose
not beyond 22 mg a day.
LGD-4033 has the ability to set off the following benefits when taken consistently:
An increase in strength levels
Lean muscle mass improved
A drop in body fat
Has healing properties
Does not cause the undesirable side effects caused by prohormones
